Sanford Health Selects Translational Software for Large-Scale Expansion of Pharmacogenomics Program to Individualize Patient Care
BELLEVUE, Wash.–(BUSINESS WIRE)–Translational Software®, Inc. (TSI), a leader in the intelligent use of genetic data for clinical decision support and precision medicine, today announced that Sanford Health, a Dakotas-based non-profit health system, and one of the largest integrated health systems in the nation, has selected TSI’s pharmacogenomics (PGx) knowledge base and PGx platform to expand its genomics program across multiple U.S. regions to personalize patient treatment and improve health outcomes throughout the Sanford Health enterprise.
“We are pleased that our new FHIR-based API technology architecture will provide a scalable PGx solution at Sanford Health. Ensuring integrated PGx results reporting, and making PGx data more accessible and less expensive, is a key element toward democratizing genomic medicine.”
Sanford Imagenetics is a comprehensive genomic medicine initiative launched in 2014 that aims to fully integrate the tools of genomic medicine into primary care for adults. This unique model uses each patient’s family history and genetic makeup to personalize treatment and facilitate the promotion of health and the management of chronic disease. One aspect of the program evaluates the genetic variability of how patients metabolize more than 22 different medications and classes of medications.
“Our goal is to provide precision medicine through the Imagenetics program so that our physicians are able to provide both personalized care and effective population health management for all Sanford Health patients as part of routine primary care,” said Cornelius F. Boerkoel, MD, PhD, Executive Director, Sanford Imagenetics Research Center on Genomic & Molecular Medicine and Executive Clinical Director, Sanford Genetics Laboratories.
TSI’s Knowledge-as-a-Service platform and Application Programming Interface (API) provides access to the company’s proprietary PGx portal and knowledge base for integrated drug-drug-gene information and clinical decision support. Clinicians are provided a tailored, clinically actionable report with concise molecular intelligence and critical alerts regarding drug efficacy, toxicity, and known drug-gene interactions. The report provides a list of all known medications for which dosing should be personalized based on the patient’s genetic test results, coupled with recommended medication alternatives and dosing guidance.
The PGx report will be integrated into the EPIC electronic health record to guide clinical decision making and enable physicians to prescribe the safest, most effective medications.
Don Rule, CEO of Translational Software, stated, “We are pleased that our new FHIR-based API technology architecture will provide a scalable PGx solution at Sanford Health. Ensuring integrated PGx results reporting, and making PGx data more accessible and less expensive, is a key element toward democratizing genomic medicine.”
With clinical reporting for nearly 40 genes, TSI’s platform can be tailored to a variety of clinical specialties including cardiovascular, psychiatric, pain and cancer as the Imagenetics program expands.
About Sanford Health
Sanford Health is an integrated health system headquartered in the Dakotas. It is one of the largest health systems in the nation with 43 hospitals and nearly 250 clinics in nine states and four countries. Sanford Health’s 27,000 employees, including 1,400 physicians, make it the largest employer in the Dakotas. Nearly $1 billion in gifts from philanthropist Denny Sanford have allowed for several initiatives, including global children’s clinics, genomic medicine and specialized centers researching cures for type 1 diabetes, breast cancer and other diseases. For more information, visit www.sanfordhealth.org.
About Translational Software, Inc.
Translational Software provides end-to-end solutions to support laboratories and healthcare providers adopting personalized medicine. Its powerful PGx portal transforms genomic and molecular data into actionable knowledge, integrating the best available clinical decision support with laboratory and clinical information systems to guide therapeutic options for medication management to enhance patient care. For more information visit www.translationalsoftware.com.
Translational Software, Inc.
Myla Wagner, 925-736-7515